In CF, those with 2 ETI-responsive CTFR variants (vs 1 variant) are twice as likely to have sweat chloride concentrations on ETI within normal range.
The FDA approved a once-daily oral combination of vanzacaftor/tezacaftor/deutivacaftor (Alyftrek) for cystic fibrosis (CF) in adults and children 6 years and up ...
Tony Arenas, who has cystic fibrosis and received a double lung transplant, was recently diagnosed with stage 4 colon cancer. Despite a lifetime of medical challenges, Arenas maintains a determined ...
This Friday, October 3rd, the Cystic Fibrosis Foundation will host its Little Rock Finest event at 6:30 p.m. in Argenta Plaza, bringing together the best of the city’s food and drink—all for one cause ...
In its 11th year, the Claire’s Place Foundation Glow Ride has become a popular event in the South Bay — attracting dozens to support those battling cystic fibrosis. The event, officially titled “Glow ...
A pair of San Diego scientists who helped develop a treatment for cystic fibrosis, a life-threatening genetic disorder that damages people’s organs, have been named recipients of a 2025 Lasker Award, ...
Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients Three scientists who revolutionized the treatment of cystic fibrosis and ...
Cystic fibrosis was once a dire, likely deadly diagnosis, destroying a patient's ability to breathe and digest food—but a revolutionary new treatment offers reason for hope. And on Thursday the three ...
Three scientists who revolutionized the treatment of cystic fibrosis and prolonged the lifespan of patients with the deadly disease have won the Lasker Award, one of the most prestigious awards in ...
Many winners of the annual Lasker Awards have gone on to win a Nobel Prize in medicine or other fields. Lucy Shapiro of Stanford University was honored for her 55-year career investigating how ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
MPR: What is non-cystic fibrosis bronchiectasis? Dr Addrizzo-Harris: Non-cystic fibrosis bronchiectasis is an abnormality of the airways in the lung where the airways become dilated, often permanently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results